{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 2186"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to\n\t\t  provide for the compounding of drug products."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130523", "#text": "May 23, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Markey", "@name-id": "M000133"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Ms. Slaughter", "@name-id": "S000480"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Clay", "@name-id": "C001049"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Rangel", "@name-id": "R000053"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H635DDF9B14B74ABA8F36FA1831C29138", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": [{"short-title": {"#tail": "\n        ", "#text": "Verifying Authority and Legality In\n\t\t\t Drug Compounding Act of 2013"}, "#tail": " or the ", "#text": "\n          "}, {"short-title": {"#tail": "\n        ", "#text": "VALID Compounding Act"}, "#tail": ".", "#text": "\n          "}], "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HD8754CD0AA014B91B21E7DCE8526FE01"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Application of\n\t\t\t Federal law to practice of pharmacy compounding"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503A of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 353a", "@value": "usc/21/353a"}, "@parsable-cite": "usc/21/353a", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Amendment"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "503A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Pharmacy\n\t\t\t\tcompounding"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "Sections\n\t\t\t\t501(a)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:501/ss:a/p:2/sp:B"}, {"#tail": ", and ", "@entity-type": "act", "#text": "502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " shall not apply with respect to a drug product\n\t\t\t\tif each of the following applies:", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}], "#text": "\n                ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the drug product is compounded for an identified individual\n\t\t\t\tpatient based on the receipt of a prescription order.", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d", "@proposed": "true"}, "#text": "Except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "H629B81D5CF684EC4A6FFC0F57E383B72", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The drug product is compounded by a\n\t\t\t\tlicensed pharmacist in a State-licensed pharmacy or a Federal facility, or by a\n\t\t\t\tlicensed physician, pursuant to such prescription order or notation.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "HB3288A14D88F41498D6C67AC65DE308C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In the case of a drug product that is\n\t\t\t\tcompounded using bulk substances (as defined in section 207.3(a)(4) of title\n\t\t\t\t21, Code of Federal Regulations (or any successor regulations)\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "#text": "\n                ", "@id": "H12A0485E80CD48929269166EE123A849", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "such bulk\n\t\t\t\tsubstances\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " is in effect;", "@entity-type": "act", "#text": "(j) of section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}], "#text": "are components of\n\t\t\t\tone or more drugs for which an approval of an application filed under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H04ECF60E504141439E614FF1AC316F1B", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "section 201", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, "#text": "are components of\n\t\t\t\tdrugs that may be lawfully marketed in the United States without such an\n\t\t\t\tapproval pursuant to the definition of a new drug in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HE9BA4299FF4F401DB3648D2192DEDDBC", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b", "@proposed": "true"}, "#text": "appear on the\n\t\t\t\tlist in effect under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "HF2E2549F97074C8A913C44BB6B45B84F", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H87D7DB7BD8EC4FEFB104DEA4137075CC"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "such bulk\n\t\t\t\tsubstances comply with the standards of an applicable United States\n\t\t\t\tPharmacopeia or National Formulary monograph, if a monograph exists."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HE798B0ED23914DCA9A4630CC044CB2E9", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Any bulk substance\n\t\t\t\tused for purposes of compounding the drug product\u2014"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "@id": "H7F2F6529684F4B8D8A4D2978621C93A0", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (including a foreign\n\t\t\t\testablishment that is registered under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": "); and", "@entity-type": "act", "#text": "section 510(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:i"}], "#text": "is manufactured by\n\t\t\t\tan establishment that is registered under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HE255287372E74F25B70832008F4DCC3F", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is accompanied by valid certificates of\n\t\t\t\tanalysis.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HA986FFF123E84BD49094099160131095", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The pharmacist or\n\t\t\t\tphysician compounding the drug product complies with the standards of any\n\t\t\t\tapplicable United States Pharmacopeia chapters on pharmacy compounding."}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "@id": "H5D1A5C893AFA4671BD8397EC859B42F1", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The drug product, including the dosage form\n\t\t\t\tand any ingredient thereof\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "#text": "\n                ", "@id": "H38D71588B78E46DFBF0B200A23E538DF", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c", "@proposed": "true"}, "#text": "is not included in\n\t\t\t\tthe list under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H62DF1AF1D9994999A53CF67932144309", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is not withdrawn or removed from the market\n\t\t\t\tbecause such drug product or any ingredient thereof has been found to be unsafe\n\t\t\t\tor not effective.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H5336224DF00647FFB621F94CB8933868", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the drug product is not a copy of a commercially available\n\t\t\t\tdrug.", "@entity-type": "act", "#text": "subsection (e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e", "@proposed": "true"}, "#text": "Subject to\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "@id": "H48F94B5362154BCC9D0CBAD3AEB85A4B", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f", "@proposed": "true"}, "#text": "If the drug product is produced using\n\t\t\t\thigh-risk sterile compounding, the drug product is compounded in accordance\n\t\t\t\twith the standards, processes, and procedures established under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(8)"}, "@id": "HEFDEA6BFDE304C74A73A2ECB452396E3", "#text": "\n                "}], "#text": "\n              ", "@id": "HDF435FE89C7A4E158AF0ED134247DDB3"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "List of bulk\n\t\t\t\tsubstances from which drug products may be compounded"}, "paragraph": [{"#tail": "\n              ", "@id": "HED1106095F944F56A7EA443AFBA633D4", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (a)(3)(A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:iii", "@proposed": "true"}, {"#tail": "\n\t\t\t\tshall, by guidance\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For purposes of "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "develop and\n\t\t\t\tmaintain a list of bulk substances from which drug products may be compounded;\n\t\t\t\tand"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H946BD3EB727E4FAE9D3A72413A61E1E8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:i", "@proposed": "true"}, {"#tail": " and may be compounded to meet a medical need that cannot\n\t\t\t\tbe filled by using a bulk substance that is described in such ", "@entity-type": "act", "#text": "(ii) of\n\t\t\t\tsubsection (a)(3)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " or\n\t\t\t\t", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:i", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:ii", "@proposed": "true"}], "#text": "include in the\n\t\t\t\tlist only bulk substances that are not described in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HA8DCF5894713468EB8D90A4CC131837F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "specify for each\n\t\t\t\tbulk substance on the list under this subsection any limitation on compounding\n\t\t\t\tthe bulk substance; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H5D392E8ED3734AF6957E317E7AD2CB35", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "specify for each\n\t\t\t\tbulk substance on the list under this subsection the particular medical need\n\t\t\t\tthat is met by placing such substance on the list."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H58B696A29315482B8981E8BE92BED5EE", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "HBD960ABB0E354A07874C90E463F171A0", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Initial\n\t\t\t\tpublication; updates"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ", publish an initial list under ", "@entity-type": "act", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013", "short-title": {"#tail": "\n                    ", "#text": "Verifying Authority and Legality In Drug Compounding Act\n\t\t\t\tof 2013"}, "#text": "\n                      "}, {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}], "#text": "not later than 1\n\t\t\t\tyear after the date of the enactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H972F1075CF5A472E8EFB158F972B3B69", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, "#text": "not less\n\t\t\t\tfrequently than every year thereafter, review and, as appropriate, update the\n\t\t\t\tlist under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HAD6E8948C8214F4EA4D9D3CDAA582BD4", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the list under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " available on the public Web\n\t\t\t\tsite of the Food and Drug Administration.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Availability"}, "#text": "\n                ", "@id": "H09887EE57C334408A09268AB7A120E9A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and upon each update to the list, the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, {"#tail": " shall transmit\n\t\t\t\tan up-to-date copy of the list to the agency in each State with primary\n\t\t\t\tresponsibility for regulating pharmacies.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon publication of the initial list under\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Transmission to\n\t\t\t\tState regulatory agencies"}, "#text": "\n                ", "@id": "HFF34B6A9B669418CA292239B90DDA4D4"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\treceive and consider petitions from any person identifying a substance that\n\t\t\t\tshould be added to, or removed from, the list under this subsection.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In carrying out this subsection, the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "HB831EA6B1033400593C5610822C3598F"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "why the bulk\n\t\t\t\tsubstance is needed for a procedure or population; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H69096BE5FA3F4C92A53444FFDB936B5C", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(ii) of\n\t\t\t\tsubsection (a)(3)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A/cl:ii", "@proposed": "true"}], "#text": "why such need is\n\t\t\t\tnot met by bulk substances that are described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H5F5F8F809EA744DC9848978295672193", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Requirement for\n\t\t\t\tpetitions seeking to add a bulk substance"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any petition seeking to\n\t\t\t\tadd a bulk substance to the list under this subsection shall specify the\n\t\t\t\treasons\u2014"}, "#text": "\n                  ", "@id": "HA7DC6C44C54E45FCABA8AA8E14FD72E2"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall approve or deny any petition received\n\t\t\t\tunder this paragraph, and update the list under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " accordingly, not\n\t\t\t\tlater than 90 days after receipt of the petition, unless an extension of time\n\t\t\t\tis mutually agreed upon by the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, {"#tail": " and the petitioner.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Approval or\n\t\t\t\tdenial"}, "#text": "\n                  ", "@id": "H356C7AF6ECC641089C70547913A82BE9"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve or deny a petition received under this paragraph shall\n\t\t\t\tconstitute final agency action subject to judicial review.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A decision of the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Final agency\n\t\t\t\taction"}, "#text": "\n                  ", "@id": "H48DC3864A0D346F2A131A707FADA8726"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "all petitions\n\t\t\t\treceived under this paragraph within 21 days of receipt; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H4BBDD2A8F8E047E492F9F26C394A28A9", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " promptly.", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:5/sp:C", "@proposed": "true"}, "#text": "each approval,\n\t\t\t\tdenial, and extension under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@display-inline": "no-display-inline", "#text": "\n                    ", "@id": "H0CBB9BD5042F4941895D795500CDE0ED"}], "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Public\n\t\t\t\tposting"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tpublically post\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "HF993A35793A24EBBAC63D41FBD5EF3E0"}], "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Petitions"}, "#text": "\n                ", "@id": "H58640BF2287A4DF68AA6054FFE7B6ED4"}], "#text": "\n              ", "@id": "H1B75AD4F5BD4439799C5C7E31F2DF005"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "List of drug\n\t\t\t\tproducts that should not be compounded"}, "paragraph": [{"#tail": "\n              ", "@id": "H5AC13D570E50408992B905A440D0DB13", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (a)(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:6", "@proposed": "true"}, {"#tail": " shall,\n\t\t\t\tby guidance\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For purposes of "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "develop and\n\t\t\t\tmaintain a list of drug products that should not be compounded, including any\n\t\t\t\tcategories, dosage forms, or ingredients of such drug products; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H19129E0D06FE42708DA9505409A0BC26", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "include on such\n\t\t\t\tlist, at a minimum\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "drug products (or categories, dosage forms,\n\t\t\t\tor ingredients thereof) whose compounding is reasonably likely to cause an\n\t\t\t\tadverse effect on safety or effectiveness of such drug product, including\n\t\t\t\textended release products, metered dose inhalers, transdermal patches, and\n\t\t\t\tliposomal products; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HF7296C42004A4069AF9EB149E5E1E4BB", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "drug products (or categories, dosage forms,\n\t\t\t\tor ingredients thereof) that have been withdrawn or removed from the market\n\t\t\t\tbecause they have been found to be unsafe or not effective.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H5EDC472B78B6467E8B4680CC394453C5", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H718F57ABFD3B416FA953C8146E19ADC6"}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraphs (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:2", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:3", "@proposed": "true"}, {"#tail": " shall apply with respect to the list under this subsection to\n\t\t\t\tthe same extent and in the same manner as such provisions apply with respect to\n\t\t\t\tthe list under ", "@entity-type": "act", "#text": "(4)\n\t\t\t\tof subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:4", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b", "@proposed": "true"}], "#text": "The provisions of "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Applicability of\n\t\t\t\tcertain provisions"}, "#text": "\n                ", "@id": "H9FA25F531E3440E19F5B885BAC54F950"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall receive and consider petitions from any person identifying a\n\t\t\t\tdrug product that should be added to, or removed from, the list under this\n\t\t\t\tsubsection. ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall apply with\n\t\t\t\trespect to petitions under this paragraph to the same extent and in the same\n\t\t\t\tmanner as such subparagraphs apply with respect to petitions under ", "@entity-type": "act", "#text": "Subparagraphs (C) through (E) of subsection (b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:2/sp:C..E", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:5", "@proposed": "true"}], "#text": "In carrying out this subsection, the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Petitions"}, "#text": "\n                ", "@id": "H0FBC00B972944E4AB6F9C9E108F823C3"}], "#text": "\n              ", "@id": "HB0B6472A865949749A1DCF892A0F6F16"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Exception to\n\t\t\t\trequirement of identified individual patient"}, "paragraph": [{"#tail": "\n              ", "@id": "H36C6A309708F46EBA5DF34D2A0A83BC7", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tGeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may compound a drug product without regard to\n\t\t\t\t", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the pharmacy or pharmacist\u2014", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1", "@proposed": "true"}], "#text": "A pharmacy or pharmacist that is not required to be\n\t\t\t\tregistered under "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as specified pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2", "@proposed": "true"}], "#text": "registers with the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "HFD8C181137C3406C9C17E63DA0DF9856", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", including the conditions and limitations specified pursuant to\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2", "@proposed": "true"}], "#text": "agrees to comply\n\t\t\t\twith any condition of operation or limitation of activity specified by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "HA324B7D9E9C347C3A4B45A649CDCB763", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "@id": "H086B86B436084B60929BD945DC6D446C", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Registration and\n\t\t\t\trequirements"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall specify by regulation for each\n\t\t\t\ttype of pharmacy or pharmacist compounding drug products pursuant to the\n\t\t\t\texception under this subsection\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the registration\n\t\t\t\trequirements for such pharmacy or pharmacist and the information that must be\n\t\t\t\tsubmitted with the registration, which information shall include\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the name and\n\t\t\t\tlocation of the pharmacy;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "H3CCE731ADA0D4DAA899BC4FEA81A22D4", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the types of\n\t\t\t\tdrugs that are compounded;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "H90CC614B697E4AF7A7E93500A99813DC", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the active\n\t\t\t\tingredients in each such drug;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "HBE163F712C7A42FB935F6B7D361E45B6", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the source and\n\t\t\t\tstrength of the active ingredient in each drug;"}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "#text": "\n                    ", "@id": "HB0FCEB276FEE46F0989290E881FF44FE", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the dosage form\n\t\t\t\tand route of administration of each drug;"}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "#text": "\n                    ", "@id": "H3EEC3B02822742C0BE4858B15BD0831C", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tindividual units produced of each drug;"}, "enum": {"#tail": "\n                    ", "#text": "(vi)"}, "#text": "\n                    ", "@id": "H4E490FE071A748E58F98DA1360E4A610", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the States to which drugs were\n\t\t\t\tshipped;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(vii)"}, "#text": "\n                    ", "@id": "H170C739056E94B6797567D490C13A0AB", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tindividual units of each drug that are shipped to each State; and"}, "enum": {"#tail": "\n                    ", "#text": "(viii)"}, "@id": "HB5750850C1934BDD8D5CD21F8566DFEC", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "affirmation that\n\t\t\t\tthe pharmacy or pharmacist is in compliance with State pharmacy licensing\n\t\t\t\tregulations;"}, "enum": {"#tail": "\n                    ", "#text": "(ix)"}, "#text": "\n                    ", "@id": "H9E68C45F8F28498B9AFBC3DF43D63E73", "@commented": "no"}], "#text": "\n                  ", "@id": "H8657164175DB4C04B0409A7EA117604B", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " must be submitted;", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}, "#text": "the frequency in\n\t\t\t\twhich information described in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "HDA8FA7FD4E19446A9BCA061E49B7D944", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the conditions of\n\t\t\t\toperation, including good manufacturing practices and requirements for\n\t\t\t\tthird-party testing, applicable to the compounding of drugs; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "HD869031868134F638D400B707E2FD227", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "any limitations on\n\t\t\t\tthe activities of such pharmacy or pharmacist."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "#text": "\n                  ", "@id": "H3F166A3C6B694F5C9790A43E1B15D368", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "@id": "H77F4727DE31F4B2BA26C948263AB0C51", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Types of\n\t\t\t\tpharmacies eligible"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify separate\n\t\t\t\trequirements for each type of pharmacy and pharmacist authorized to compound\n\t\t\t\tdrug products pursuant to the exception under this subsection. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall include separate requirements for\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "any pharmacy or\n\t\t\t\tpharmacist within a hospital system that is compounding drug products\n\t\t\t\texclusively for dispensing to patients within that hospital system; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "H07B3F2F97E7D4EFCBD06AB735A410C2D", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "any pharmacy or\n\t\t\t\tpharmacist that compounds sterile drug products."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "H89F3CE26C984449EA815D68B2007ACEB", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "ensuring, to the\n\t\t\t\tSecretary\u2019s satisfaction, that the State will implement the exception under\n\t\t\t\tthis subsection in accordance with the requirements of this section; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "HA69BDD50F49E47FDB7642BCA2B819D56", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "including such\n\t\t\t\tother information and assurances as the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "H6595D78C298C42DDA44ED842F6F3715A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4/sp:C", "@proposed": "true"}, {"#tail": " may enter into appropriate memoranda of\n\t\t\t\tunderstanding with States to address State implementation of the exception\n\t\t\t\tunder this subsection\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Subject to\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "HCE0520396C6648B6B8009A6F96A06A9C", "@commented": "no"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "establish a\n\t\t\t\tprocess and criteria for entering into a memorandum of understanding under this\n\t\t\t\tparagraph, including the sharing of information between State and Federal\n\t\t\t\tauthorities; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "H5D172DC8D0BB49CA83DA47CCAD2C339E", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s\n\t\t\t\tsatisfaction, that the State\u2019s implementation of the memorandum of\n\t\t\t\tunderstanding continues to conform to the requirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "reevaluate each such memorandum of\n\t\t\t\tunderstanding not less than every 5 years to ensure, to the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "HC7A414C28E4F47DDB0550760BD025358", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Process;\n\t\t\t\tcriteria"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n                  ", "@id": "HD3C986F494554F27992DDA7B3CFA0C8D", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "perform high-risk\n\t\t\t\tsterile compounding; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "HB961CDADB08546C98DC8DC4E2F336C73", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compound drug\n\t\t\t\tproducts for shipment across State lines."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "H482571654C2A444BB2BC11A03CC9D6BE", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Exclusive\n\t\t\t\tFederal authority"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall retain exclusive Federal authority to implement the exception\n\t\t\t\tunder this subsection with respect to pharmacies and pharmacists that\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "H0AE8E6F63C6E4B20BC1FABF899F7C833", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Memorandum of\n\t\t\t\tunderstanding"}, "#text": "\n                ", "@id": "HC85F1F6969D94033A9E4F931916B4A37", "@commented": "no"}, {"#tail": "\n            ", "@id": "H9414B6D680114EC79F02ADD1D4127560", "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Maintenance of\n\t\t\t\tlist"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall maintain a publically available\n\t\t\t\tlist\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "identifying all\n\t\t\t\tpharmacies and pharmacists registered under this subsection; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H73027F8793834A00A400F6F73D1D2955", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4", "@proposed": "true"}, "#text": "indicating, for\n\t\t\t\teach such pharmacy and pharmacist, whether the pharmacy or pharmacist is\n\t\t\t\tsubject to regulation by a State pursuant to a memorandum of understanding in\n\t\t\t\teffect under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H2D33B59B56B643F1B72E8587B5773089", "#text": "\n                  "}], "@commented": "no"}], "#text": "\n              ", "@id": "H413E41838014483F8E0273E90609C6A9", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " if\u2014", "@entity-type": "act", "#text": "subsection (a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:7", "@proposed": "true"}, "#text": "A drug that is a\n\t\t\t\tcopy of a commercially available drug may be compounded pursuant to this\n\t\t\t\tsection without regard to "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Exceptions\n\t\t\t\tregarding copies of commercially available drugs"}, "paragraph": [{"#tail": "\n              ", "@id": "H9167F5B9D64541BE86C30A3325B8E751", "enum": {"#tail": "\n                ", "#text": "(1)"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that such drug is being compounded not later than 5 days after\n\t\t\t\tdistributing such drug; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the commercially\n\t\t\t\tavailable drug that is being compounded is at the time of distribution on the\n\t\t\t\tdrug shortage list under section 506E, and the pharmacy has provided notice to\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "H778B1495695E42ECB39B332B03ED2983", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines that com\u00adpound\u00ading\n\t\t\t\tthe drug product is necessary to protect public health or wellbeing; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "H9D140E0D318E4C738BB2868BBE29D3AC"}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tcommercially available drug marketed pursuant to a risk evaluation and\n\t\t\t\tmitigation strategy approved under section 505\u20131 and including one or more\n\t\t\t\telements to assure safe use, the pharmacy or pharmacist compounding the drug\n\t\t\t\tthat is a copy of such commercially available drug demonstrates to the\n\t\t\t\tSecretary that controls will be used that are comparable to such elements to\n\t\t\t\tassure safe use."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "H7809257C270444A5ACCC0D82986068F3", "#text": "\n                "}], "#text": "\n              ", "@id": "H709BC58FF26D458C8081BF44217C47C7"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (a)(8)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:8", "@proposed": "true"}, {"#tail": " shall establish standards,\n\t\t\t\tprocesses, and procedures for high-risk sterile compounding.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For\n\t\t\t\tpurposes of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n              ", "#text": "High-Risk\n\t\t\t\tsterile compounding"}, "#text": "\n              ", "@id": "HA905B2E5339347008996D4C8FD2ECCF5"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the\n\t\t\t\tfacilities of any pharmacy or pharmacist compounding drug products under this\n\t\t\t\tsection\u2014", "@entity-type": "act", "#text": "section 704(a)(2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2/sp:A"}, "#text": "Notwithstanding ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n              ", "#text": "Inspections"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, "#text": "shall be subject\n\t\t\t\tto inspection under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "H55CEB438B61747E290A002E9BD53FA26", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", permit such\n\t\t\t\tofficer or employee at all reasonable times to have access to, and to copy and\n\t\t\t\tverify, records for purposes of determining compliance with the provisions of\n\t\t\t\tthis Act applicable to such compounding.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "shall, upon\n\t\t\t\trequest of an officer or employee designated by the "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "HCC8FF35969AC4E2E9600F4ABDE2CB1EF", "#text": "\n                "}], "#text": "\n              ", "@id": "H7192D002B4B54B359FA8A1F9EFE72D2A"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " discovers a violation of this Act, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall give notice of\n\t\t\t\tthe violation\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If during an\n\t\t\t\tinspection of the facilities of a pharmacy or pharmacist under this section the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Sharing of\n\t\t\t\tinformation"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to the State in\n\t\t\t\twhich the facilities are located; and"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "HDA446A08D4D54788AE9B2D2D3C5BAF37", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to any State to\n\t\t\t\twhich the pharmacy or pharmacist has shipped a drug product during the\n\t\t\t\tpreceding 30 days."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "HEBA18B2EB8B94B3599D856E5168B1BC1", "#text": "\n                "}], "#text": "\n              ", "@id": "HA7F050E2832748CEBC80C17D099BFCB2"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The labeling of any drug product compounded\n\t\t\t\tpursuant to this section shall include\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Labeling"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the name of each drug and ingredient\n\t\t\t\tincluded;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "H1799716F441B4559841E13A32559C16D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the name, address,\n\t\t\t\tand phone number of the licensed compounding pharmacy, pharmacist, or\n\t\t\t\tphysician;"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "H3F152C16F76A45DEA0A38C9D39BD985C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the date on which\n\t\t\t\tthe drug was compounded;"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "@id": "H2F807AF742394872AB23E0671DEBB009", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "instructions for\n\t\t\t\tstorage and use;"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "@id": "H58583D7D6F5546E2998ABCB8DC720F54", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": {"#tail": " (The blank shall specify a phone number and\n\t\t\t\ta Web site, to be provided by the ", "#text": "This drug has not been tested for safety and effectiveness\n\t\t\t\tand is not approved by the FDA. This drug was made specifically for you because\n\t\t\t\tyour health care provider determined that no FDA-approved product would suit\n\t\t\t\tyour needs. Serious adverse reactions to this drug should be reported to the\n\t\t\t\tFDA at ________________, to the pharmacy where the drug was received, and to\n\t\t\t\tyour health care provider."}, "#text": "the following\n\t\t\t\tstatement: ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for purposes of this subsection.);\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "@id": "H43E4D91AE1C14956966955F495326FE3", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "such other\n\t\t\t\tinformation as the "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "@id": "H36E3B904E4E5441BAC400638A918B608", "#text": "\n                "}], "#text": "\n              ", "@id": "H9E9042C087B947179B13E0B9B176D5A7"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reporting by\n\t\t\t\tpharmacists and physicians"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If a pharmacist or physician compounding a drug product\n\t\t\t\tpursuant to this section becomes aware of any adverse event associated with the\n\t\t\t\tuse of such product, not later than 10 calendar days after becoming so aware,\n\t\t\t\tthe pharmacist or physician shall report such adverse event to the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Adverse\n\t\t\t\tevent"}, "#text": "\n                ", "@id": "H4848CF31F02D42D589820340A12E7ADB"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "If a pharmacist or physician compounding a\n\t\t\t\tdrug product pursuant to this section becomes aware of information concerning\n\t\t\t\tany bacteriological, fungal, or other contamination; any significant chemical,\n\t\t\t\tphysical, or other change; or any deterioration of a compounded drug product\n\t\t\t\tthat has already been distributed by the pharmacist or physician, that could\n\t\t\t\tcause serious injury or death, not later than 2 calendar days after becoming so\n\t\t\t\taware, the pharmacist or physician shall report such information to the\n\t\t\t\tSecretary.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Information\n\t\t\t\trelated to risk of injury or death"}, "#text": "\n                ", "@id": "HA78DDD09217447C9B4B82686D774D817", "@commented": "no"}], "#text": "\n              ", "@id": "HC9BFE751985C4AE088799B0A7671A15A"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\testablishment and reinspection fees"}, "paragraph": [{"#tail": "\n              ", "@id": "HFB2CBAFDA145432CB55D6A48D995C62B", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis subsection\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " has the\n\t\t\t\tmeaning given such term in ", "#text": "affiliate"}, "#text": "the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H0E388FD248E143E38CDF0A688313F056", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (the exception to the requirement of an identified individual\n\t\t\t\tpatient)\u2014", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d", "@proposed": "true"}, "term": {"#tail": " means a pharmacy that, pursuant to\n\t\t\t\t", "#text": "covered compounding pharmacy"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "performs high-risk\n\t\t\t\tsterile compounding;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H7EA5C55E7F234F32B956B6123C8550C3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounds drug\n\t\t\t\tproducts for shipment across State lines; or"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HB4F3AFE9EB414229B032219C65A52F24", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that is not regulated by a\n\t\t\t\tState pursuant to a memorandum of understanding under ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "subsection (d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4", "@proposed": "true"}], "#text": "otherwise\n\t\t\t\tperforms compounding pursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H8AFBADBE14AF40EF9071D47AD8785983", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H5BD3FA4855954B0F8B275EB73E22A293"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the total worldwide gross annual sales,\n\t\t\t\tin United States dollars, for a covered com\u00adpound\u00ading pharmacy, including the\n\t\t\t\tsales of all the affiliates of the covered compounding pharmacy; and", "#text": "gross annual sales"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H6E0CC1D6181A427794B26FBF09EAE9F3", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " subsequent to an\n\t\t\t\tinspection conducted under such provision which identified noncompliance\n\t\t\t\tmaterially related to an applicable requirement of this Act, specifically to\n\t\t\t\tdetermine whether compliance has been achieved to the ", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, {"#tail": "\u2019s\n\t\t\t\tsatisfaction.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means, with respect to a covered compounding\n\t\t\t\tpharmacy, one or more inspections conducted under ", "#text": "reinspection"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H384F996E17034175BE577120B50FC7CD", "#text": "\n                  "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "an\n\t\t\t\tannual establishment fee from each covered compounding pharmacy; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H9FDC821FBCBE4695A169C009C9C153E9", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\treinspection fee from each covered compounding pharmacy subject to a\n\t\t\t\treinspection in such fiscal year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H3AAC409EFCD94F62BE1C878DCDFD4543", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, in accordance with this subsection, assess and collect\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "For fiscal year 2015 and each subsequent fiscal year, the\n\t\t\t\t"}, "#text": "\n                  ", "@id": "H543E9BBC8BB24C58B702E06F66AFBBD1"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A covered compounding pharmacy subject to multiple\n\t\t\t\treinspections in a fiscal year shall be subject to a reinspection fee for each\n\t\t\t\treinspection."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Multiple\n\t\t\t\treinspections"}, "#text": "\n                  ", "@id": "H49FD3212F3DC4D6FB931DF4A25928EBC"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Establishment\n\t\t\t\tand reinspection fees"}, "#text": "\n                ", "@id": "H14A56F8BB9E94D5498DC7103264549DD"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish the\n\t\t\t\testablishment and reinspection fee to be collected under this subsection for\n\t\t\t\teach fiscal year, based on the methodology described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and shall\n\t\t\t\tpublish such fee in a Federal Register notice not later than 60 days before the\n\t\t\t\tstart of each such year.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fee setting"}, "#text": "\n                ", "@id": "H6D6F7813F94B414782F6B55D38DBE02B"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the amount of the annual establishment fee under ", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:D", "@proposed": "true"}, {"#tail": " shall be equal to the sum of\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:2", "@proposed": "true"}], "#text": "except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tplus", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:B", "@proposed": "true"}, "#text": "$15,000,\n\t\t\t\tmultiplied by the inflation adjustment factor described in "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H7B7DB4D2B4BE44F8A81155B78FEFBA28", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:C", "@proposed": "true"}, "#text": "the small\n\t\t\t\tbusiness adjustment factor described in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H5F10E13296024A4AAF99A4B9F119A51A", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H9221A02893734841BA66B99C1144747B"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be equal to $15,000,\n\t\t\t\tmultiplied by the inflation adjustment factor described in ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:B", "@proposed": "true"}], "#text": "the amount of any\n\t\t\t\treinspection fee (if applicable) under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H3110B1D252A44EC58A46E9D5713DA012", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "For each covered compounding pharmacy in a fiscal\n\t\t\t\tyear\u2014"}, "#text": "\n                  ", "@id": "H60D2CC03270445F1942556E02C8D0E8D"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H48E0DD1FCA3B4758BFA27C52B8C5FD44", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears, multiplied by the proportion of personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " for the first 3 years of the preceding 4 fiscal years;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}], "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H3420CB4578334596AF940380F1658969", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears.", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, "#text": "the average\n\t\t\t\tannual percent change that occurred in the Consumer Price Index for urban\n\t\t\t\tconsumers (U.S. City Average; Not Seasonally Adjusted; All items; Annual Index)\n\t\t\t\tfor the first 3 years of the preceding 4 years of available data multiplied by\n\t\t\t\tthe proportion of all costs other than personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the "}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "HAE72F26D9EAF452690F7A41321FA3D8B", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:A", "@proposed": "true"}, {"#tail": " by\n\t\t\t\tnotice, published in the Federal Register, for a fiscal year by the amount\n\t\t\t\tequal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the fee\n\t\t\t\tamounts established in "}, "#text": "\n                    ", "@id": "HBBF293C876C641D0B674789217E85D84"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tbe added on a compounded basis to the sum of all adjustments made each fiscal\n\t\t\t\tyear after fiscal year 2014 under ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:B/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:B/cl:i", "@proposed": "true"}], "#text": "The adjustment made each fiscal year under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Compounded\n\t\t\t\tbasis"}, "#text": "\n                    ", "@id": "HE7F71419262248E787646695A46C87B8"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Inflation\n\t\t\t\tadjustment factor"}, "#text": "\n                  ", "@id": "H54DCBC9AE8BB4AD6A08978A173065AB8"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tsmall businesses that will pay a reduced establishment fee for such fiscal\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H37B32C7E0D914D77B086A1B2ED4BC7B6", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " would have collected if no entity qualified for the small\n\t\t\t\tbusiness exception in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:D", "@proposed": "true"}], "#text": "the adjustment to\n\t\t\t\tthe establishment fee necessary to achieve total fees equaling the total fees\n\t\t\t\tthat the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HE5D15D933BE94AD7B2A18664EFB05B13", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Small business\n\t\t\t\tadjustment factor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be an amount established by the ", "@entity-type": "act", "#text": "subparagraph (A)(i)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:A/cl:i/scl:II", "@proposed": "true"}, {"#tail": " for\n\t\t\t\teach fiscal year based on the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2019s estimate of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The small business adjustment factor referred\n\t\t\t\tto "}, "#text": "\n                  ", "@id": "H6A5FF5F6A2A94B82B96D518CE560644B"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year shall be equal to ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:2", "@proposed": "true"}, {"#tail": " in such fiscal year.", "@entity-type": "act", "#text": "subparagraph (A)(i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:A/cl:i/scl:I", "@proposed": "true"}], "#text": "In the case of a covered compounding pharmacy with gross\n\t\t\t\tannual sales of $1,000,000 or less in the 12 months ending April 1 of the\n\t\t\t\tfiscal year immediately preceding the fiscal year in which the fees under this\n\t\t\t\tsubsection are assessed, the amount of the establishment fee under ", "fraction": {"#tail": " of the amount\n\t\t\t\tcalculated under ", "#text": "1/3"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "HEF52E5501D6E4B398549CF848E579D23"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " a written request for such exception, in a format\n\t\t\t\tspecified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in guidance, certifying its gross annual sales for\n\t\t\t\tthe 12 months ending April 1 of the fiscal year immediately preceding the\n\t\t\t\tfiscal year in which fees under this subsection are assessed. Any such\n\t\t\t\tapplication must be submitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not later than April 30 for the\n\t\t\t\tfollowing fiscal year. Any statement or representation made to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall be subject to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "\n                        ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1001", "#text": "section 1001", "@legal-doc": "usc"}, "@value": "usc/18/1001"}], "#text": "To\n\t\t\t\tqualify for the exception under this subparagraph, a small business shall\n\t\t\t\tsubmit to the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Application"}, "#text": "\n                    ", "@id": "H7F52B10C4D1941CC810F6A708CB92245"}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exception for\n\t\t\t\tsmall businesses"}, "#text": "\n                  ", "@id": "H0796015473F2442ABF81073BEB142E9A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year, the ", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:4/sp:C", "@proposed": "true"}, {"#tail": " shall provide for the\n\t\t\t\tcrediting of fees from the previous year to the next year if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\toverestimated the amount of the small business adjustment factor for such\n\t\t\t\tprevious fiscal year, and consider the need to account for any adjustment of\n\t\t\t\tfees and such other factors as the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the small business adjustment factor under\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Crediting of\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "H61078909DC5C4F9E9097B913C3AA868E"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Amount of\n\t\t\t\testablishment fee and reinspection fee"}, "#text": "\n                ", "@id": "H85B7B549461D4F9F9DACDC553786998A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make all of the fees collected pursuant\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " available solely to pay for the\n\t\t\t\tcosts of oversight of covered compounding pharmacies.", "@entity-type": "act", "#text": "(ii) of paragraph (2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Use of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "H879561991DF34786A862ED5C094CD723"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " pursuant to this\n\t\t\t\tsubsection shall be used to supplement and not supplant any other Federal funds\n\t\t\t\tavailable to carry out the activities described in this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Funds received by the "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Supplement not\n\t\t\t\tsupplant"}, "#text": "\n                ", "@id": "HC79706F205D94B4B99EC4847E84B5FB5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " salaries and expenses appropriation account\n\t\t\t\twithout fiscal year limitation to such appropriation account for salaries and\n\t\t\t\texpenses with such fiscal year limitation. The sums transferred shall be\n\t\t\t\tavailable solely for the purpose of paying the costs of oversight of covered\n\t\t\t\tcompounding pharmacies.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Fees authorized under this subsection shall\n\t\t\t\tbe collected and available for obligation only to the extent and in the amount\n\t\t\t\tprovided in advance in appropriations Acts. Such fees are authorized to remain\n\t\t\t\tavailable until expended. Such sums as may be necessary may be transferred from\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "#text": "\n                ", "@id": "H0646FFA79C7C45E59BE3278516EB2763"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such fiscal year.", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d", "@proposed": "true"}, "#text": "A covered compounding pharmacy shall remit the establishment\n\t\t\t\tfee due under this subsection in a fiscal year when submitting a registration\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Establishment\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "H963522C08A204917B7A395D9C55F0647"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify in the Federal Register notice\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the manner in which reinspection fees assessed under\n\t\t\t\tthis subsection shall be collected and the timeline for payment of such fees.\n\t\t\t\tSuch a fee shall be collected after the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k/p:3", "@proposed": "true"}, {"#tail": " has conducted a reinspection\n\t\t\t\tof the covered compounding pharmacy involved.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Reinspection\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "H7BCB438E7AED4403BA7CD91CA9D34DBB"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in a fiscal year until the date that the covered compounding\n\t\t\t\tpharmacy remits the establishment fee under this subsection for such fiscal\n\t\t\t\tyear.", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d", "@proposed": "true"}, "#text": "A\n\t\t\t\tcovered compounding pharmacy shall not be considered registered under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Registration"}, "#text": "\n                    ", "@id": "H3FB50D57C2CA4FE0B9B9C2886AF27608"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " until the fees owed for such covered compounding pharmacy under\n\t\t\t\tthis subsection have been paid.", "@entity-type": "act", "#text": "section 502(cc)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:cc"}, "#text": "All\n\t\t\t\tdrugs manufactured, prepared, propagated, compounded, or processed by a covered\n\t\t\t\tcompounding pharmacy for which any establishment fee or reinspection fee has\n\t\t\t\tnot been paid as required by this subsection shall be deemed misbranded under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Misbranding"}, "#text": "\n                    ", "@id": "H14D1740C349A4EF6BEB07E6F26126E58"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Effect of\n\t\t\t\tfailure to pay fees"}, "#text": "\n                  ", "@id": "HBB68E663F6094740ABB69FC621CFD25A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive\n\t\t\t\tpayment of a fee assessed under this subsection within 30 days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\tprovisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States\n\t\t\t\tCode", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n                  ", "@id": "H64AD819DB3CD46288CA4495730CBCFD9"}], "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collection of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "HFA576B7DEF83453590A3D8EA8DA09104"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit a report to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", to include a description of fees\n\t\t\t\tassessed and collected for each year, a summary description of entities paying\n\t\t\t\tthe fees, and the number of inspections and reinspections of such entities\n\t\t\t\tperformed each year.", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "Not later than 120\n\t\t\t\tdays after each fiscal year in which fees are assessed and collected under this\n\t\t\t\tsubsection, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Annual report to\n\t\t\t\tcongress"}, "#text": "\n                ", "@id": "H45B2B3B7E29F4B27ABD5E5E1E7EE2590"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "an\n\t\t\t\tamount equivalent to the total amount of fees assessed for such fiscal year\n\t\t\t\tunder this subsection", "@amount": "indefinite", "@year": "2015,.."}, "@entity-type": "auth-auth-approp", "#text": "For fiscal year 2015 and each subsequent fiscal\n\t\t\t\tyear, there is authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}property": {"#tail": " ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "this subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}, "#text": "for fees under ", "@name": "purpose"}}}, "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Authorization\n\t\t\t\tof appropriations"}, "#text": "\n                ", "@id": "H7B477386E72B41B6B65CAF4FD12EDF61"}], "#text": "\n              ", "@id": "HC9BBBF37E15D4EC6849554D9DCC42F3C"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In this section:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(l)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "compound"}, {"#tail": "\u2014", "#text": "com\u00adpound\u00ading"}], "#text": "The terms ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "#text": "\n                ", "@id": "H2F77A7A3173C42BDBBCACF274B84C4A5", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "do not include\n\t\t\t\tmixing, reconstituting, or other such acts that are performed in accordance\n\t\t\t\twith directions contained in approved labeling provided by the product's\n\t\t\t\tmanufacturer and other manufacturer directions consistent with that labeling;\n\t\t\t\tand"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H7DA74EBF8AB5429E9892E6717BEFC4ED", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " or a physician who is an\n\t\t\t\t", "#text": "authorized nuclear pharmacist"}, {"#tail": " (as such terms are defined in section 35.2 of\n\t\t\t\ttitle 10, Code of Federal Regulations, (or any successor regulations)).", "#text": "authorized user"}], "#text": "in the case of a\n\t\t\t\tradioactive drug (as defined in ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations)), also do not include a minor\n\t\t\t\tdeviation from such directions with regard to radioactivity, volume, or\n\t\t\t\tstability, that is made by or under the direct supervision of an\n\t\t\t\t", "@parsable-cite": "usc/21/310", "#text": "section 310.3(n)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H13B6DE915B0B483E93D79B8C9FCC970D", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " does not include a drug product in which there is\n\t\t\t\ta change, made for an identified individual patient, which produces for that\n\t\t\t\tpatient a significant difference, as determined by the prescribing\n\t\t\t\tpractitioner, between the compounded drug and the comparable commercially\n\t\t\t\tavailable drug product, provided that in the case of a radioactive drug (as\n\t\t\t\tdefined in ", "#text": "copy of a commercially\n\t\t\t\tavailable drug product"}, "#text": "The term ", "external-xref": {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulations)), the reasons for the determination by the prescribing\n\t\t\t\tpractitioner have been documented and such documentation is maintained by the\n\t\t\t\tpharmacy.", "@parsable-cite": "cfr/21/310.3", "#text": "section 310.3(n)", "@legal-doc": "regulation"}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "H005BC040DFFD42088EDEF0F79CB5139D", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means compounding sterile drug\n\t\t\t\tproducts using nonsterile ingredients, nonsterile devices, or nonsterile\n\t\t\t\tcomponents.", "#text": "high-risk sterile compounding"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "@id": "H4981E3B4561E478FB6F10BB2D78AFC79", "#text": "\n                "}], "#text": "\n              ", "@id": "HE769446CEDF54890AB3BE58C0643387A"}], "#text": "\n            ", "@id": "H7852A4545A844F6FB6D42EFE4EFC428B"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H9466012D143C4D9388A3DEA05BC6D6E9"}, "#text": "\n        ", "@id": "H74071B3430A9418D90BE2C07DBD12396"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 502 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Misbranding"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and its labeling does not include the information required by\n\t\t\t\t", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 503A(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:i", "@proposed": "true"}], "#text": "If it is a drug product compounded pursuant\n\t\t\t\tto ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(bb)"}, "@id": "H26359F3630FA40B18F9F92CCB8CD5658", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t503A(k)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:k", "@proposed": "true"}, "#text": "If it is a drug, and it was manufactured,\n\t\t\t\tprepared, propagated, compounded, or processed by a compounding manufacturer\n\t\t\t\tfor which fees have not been paid as required by ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(cc)"}, "@id": "HD6DBB52930F347D8826D756F051B60B1", "#text": "\n            "}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H4D85C871471348C5A48233C7EAE8ABE6"}, "#text": "\n        ", "@id": "HDC032BA5214F4FA9A815FAD80D6085E1"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " before ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}, "#text": "subject to\n\t\t\t "}, {"#tail": ".", "#text": "pharmacies which maintain\n\t\t\t establishments"}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 704(a)(2)(A) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2/sp:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 374(a)(2)(A)", "@value": "usc/21/374/a/2/A"}, "@parsable-cite": "usc/21/374", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n        ", "@id": "HDAA222905D154970B094877C3105B9BA"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall promulgate final regulations for\n\t\t\t carrying out the amendments made by ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:a", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(b)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(c)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:c", "@proposed": "true"}], "#text": "Not later than 1 year after the date of the\n\t\t\t enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Regulations"}, "#text": "\n        ", "@id": "HFA21CF1CC1AF48C8B870285A9F923F3D"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:a", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(b)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:b", "@proposed": "true"}, {"#tail": " shall take effect on the date that is 1 year\n\t\t\t after the date of the enactment of this Act.", "@entity-type": "act", "#text": "(c)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:2/ss:c", "@proposed": "true"}], "#text": "The amendments made by\n\t\t\t ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "H8B4E25DCE6964A0087D7335F508E2667"}], "#text": "\n      ", "@id": "HA3406042AF55492E89F1E2F0818BA8A6"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Registration of\n\t\t\t manufacturers com\u00adpound\u00ading drug products"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not apply with respect to any pharmacy to the extent to which the\n\t\t\t pharmacy is, in effect, manufacturing such drugs, as determined by the\n\t\t\t ", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:g/p:1"}, {"#tail": ", taking into consideration the extent to which such pharmacy sells\n\t\t\t the drugs across State lines, the quantity of the drugs sold, and any other\n\t\t\t factors determined appropriate by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "With respect to compounding drugs, the exemption in "}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following: ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 510(g) of the Federal Food, Drug,\n\t\t\t and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:g"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 360(g)", "@value": "usc/21/360/g"}, "@parsable-cite": "usc/21/360", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Registration"}, "#text": "\n        ", "@id": "HA2BDB68B50384E9893E3F453788653F3"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall promulgate regulations for carrying out the\n\t\t\t amendment made by ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:3/ss:a", "@proposed": "true"}], "#text": "Not\n\t\t\t later than 1 year after the date of the enactment of this Act, the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regulations"}, "#text": "\n        ", "@id": "HDE88EA571D08476A9B412250C98709DF"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall take effect on\n\t\t\t the date that is 1 year after the date of the enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Verifying Authority and Legality In Drug Compounding Act of 2013/s:3/ss:a", "@proposed": "true"}, "#text": "The amendment made by "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "H4D32EEA79ABA463DBC2A592BF8707485"}], "#text": "\n      ", "@id": "H145F8E27D8C44EF4A83DAA54AAEAA562"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "The requirements of this Act (including the\n\t\t\t requirements of the amendments made by this Act) do not preempt any non-Federal\n\t\t\t requirement that is in addition to, and compatible with, such\n\t\t\t requirements.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "No preemption of\n\t\t\t additional non-Federal requirements"}, "#text": "\n      ", "@id": "H112C5D378530475B923CBB273FC181AD", "@commented": "no"}], "#text": "\n\t\t", "@id": "H8FB3AEC48CB849899076651C274C23E5"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-23"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 2186 IH: Verifying Authority and Legality In Drug Compounding Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}